Global Non-recombinant Coagulation Factors Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Non-recombinant Coagulation Factors market size was valued at US$ million in 2022. With growing demand in downstream market, the Non-recombinant Coagulation Factors is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Non-recombinant Coagulation Factors market. Non-recombinant Coagulation Factors are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-recombinant Coagulation Factors. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-recombinant Coagulation Factors market.
Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.
Key Features:
The report on Non-recombinant Coagulation Factors market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-recombinant Coagulation Factors market. It may include historical data, market segmentation by Type (e.g., Coagulation Factor VIII, Human Fibrinogen), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-recombinant Coagulation Factors market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-recombinant Coagulation Factors market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-recombinant Coagulation Factors industry. This include advancements in Non-recombinant Coagulation Factors technology, Non-recombinant Coagulation Factors new entrants, Non-recombinant Coagulation Factors new investment, and other innovations that are shaping the future of Non-recombinant Coagulation Factors.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-recombinant Coagulation Factors market. It includes factors influencing customer ' purchasing decisions, preferences for Non-recombinant Coagulation Factors product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-recombinant Coagulation Factors market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-recombinant Coagulation Factors market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-recombinant Coagulation Factors market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-recombinant Coagulation Factors industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-recombinant Coagulation Factors market.
Market Segmentation:
Non-recombinant Coagulation Factors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Non-recombinant Coagulation Factors market?
What factors are driving Non-recombinant Coagulation Factors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-recombinant Coagulation Factors market opportunities vary by end market size?
How does Non-recombinant Coagulation Factors break out type, application?
According to our LPI (LP Information) latest study, the global Non-recombinant Coagulation Factors market size was valued at US$ million in 2022. With growing demand in downstream market, the Non-recombinant Coagulation Factors is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Non-recombinant Coagulation Factors market. Non-recombinant Coagulation Factors are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-recombinant Coagulation Factors. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-recombinant Coagulation Factors market.
Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.
Key Features:
The report on Non-recombinant Coagulation Factors market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-recombinant Coagulation Factors market. It may include historical data, market segmentation by Type (e.g., Coagulation Factor VIII, Human Fibrinogen), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-recombinant Coagulation Factors market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-recombinant Coagulation Factors market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-recombinant Coagulation Factors industry. This include advancements in Non-recombinant Coagulation Factors technology, Non-recombinant Coagulation Factors new entrants, Non-recombinant Coagulation Factors new investment, and other innovations that are shaping the future of Non-recombinant Coagulation Factors.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-recombinant Coagulation Factors market. It includes factors influencing customer ' purchasing decisions, preferences for Non-recombinant Coagulation Factors product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-recombinant Coagulation Factors market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-recombinant Coagulation Factors market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-recombinant Coagulation Factors market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-recombinant Coagulation Factors industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-recombinant Coagulation Factors market.
Market Segmentation:
Non-recombinant Coagulation Factors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Coagulation Factor VIII
- Human Fibrinogen
- Others
- Hemophilia
- Fibrinogen Deficiency
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceutical
- Instituto Grifols SA
- CSL Behring LLC
- KM Biologics KK
- Baxter Healthcare Corp.
- Sanquin
- Johnson & Johnson
- Octapharma AG
- Bio Products Laboratory Ltd.
- Grifols Biologicals, Inc.
- Pfizer Inc.
- Intas Biopharmaceuticals Ltd.
- Shandong Taibang Biological Products
- Sinopharm Group Shanghai Blood Products
- SHANGHAI RAAS
- China Resources Boya Bio-Pharmaceutical
- Chengdu Rongsheng Pharmaceuticals
- Yuanda Shuyang Pharmaceutical
- HUALAN BIO
What is the 10-year outlook for the global Non-recombinant Coagulation Factors market?
What factors are driving Non-recombinant Coagulation Factors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-recombinant Coagulation Factors market opportunities vary by end market size?
How does Non-recombinant Coagulation Factors break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-recombinant Coagulation Factors Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-recombinant Coagulation Factors by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-recombinant Coagulation Factors by Country/Region, 2018, 2022 & 2029
2.2 Non-recombinant Coagulation Factors Segment by Type
2.2.1 Coagulation Factor VIII
2.2.2 Human Fibrinogen
2.2.3 Others
2.3 Non-recombinant Coagulation Factors Sales by Type
2.3.1 Global Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
2.3.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-recombinant Coagulation Factors Sale Price by Type (2018-2023)
2.4 Non-recombinant Coagulation Factors Segment by Application
2.4.1 Hemophilia
2.4.2 Fibrinogen Deficiency
2.4.3 Other
2.5 Non-recombinant Coagulation Factors Sales by Application
2.5.1 Global Non-recombinant Coagulation Factors Sale Market Share by Application (2018-2023)
2.5.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-recombinant Coagulation Factors Sale Price by Application (2018-2023)
3 GLOBAL NON-RECOMBINANT COAGULATION FACTORS BY COMPANY
3.1 Global Non-recombinant Coagulation Factors Breakdown Data by Company
3.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Company (2018-2023)
3.1.2 Global Non-recombinant Coagulation Factors Sales Market Share by Company (2018-2023)
3.2 Global Non-recombinant Coagulation Factors Annual Revenue by Company (2018-2023)
3.2.1 Global Non-recombinant Coagulation Factors Revenue by Company (2018-2023)
3.2.2 Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2018-2023)
3.3 Global Non-recombinant Coagulation Factors Sale Price by Company
3.4 Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-recombinant Coagulation Factors Product Location Distribution
3.4.2 Players Non-recombinant Coagulation Factors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
4.1 World Historic Non-recombinant Coagulation Factors Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-recombinant Coagulation Factors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-recombinant Coagulation Factors Market Size by Country/Region (2018-2023)
4.2.1 Global Non-recombinant Coagulation Factors Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-recombinant Coagulation Factors Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-recombinant Coagulation Factors Sales Growth
4.4 APAC Non-recombinant Coagulation Factors Sales Growth
4.5 Europe Non-recombinant Coagulation Factors Sales Growth
4.6 Middle East & Africa Non-recombinant Coagulation Factors Sales Growth
5 AMERICAS
5.1 Americas Non-recombinant Coagulation Factors Sales by Country
5.1.1 Americas Non-recombinant Coagulation Factors Sales by Country (2018-2023)
5.1.2 Americas Non-recombinant Coagulation Factors Revenue by Country (2018-2023)
5.2 Americas Non-recombinant Coagulation Factors Sales by Type
5.3 Americas Non-recombinant Coagulation Factors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-recombinant Coagulation Factors Sales by Region
6.1.1 APAC Non-recombinant Coagulation Factors Sales by Region (2018-2023)
6.1.2 APAC Non-recombinant Coagulation Factors Revenue by Region (2018-2023)
6.2 APAC Non-recombinant Coagulation Factors Sales by Type
6.3 APAC Non-recombinant Coagulation Factors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-recombinant Coagulation Factors by Country
7.1.1 Europe Non-recombinant Coagulation Factors Sales by Country (2018-2023)
7.1.2 Europe Non-recombinant Coagulation Factors Revenue by Country (2018-2023)
7.2 Europe Non-recombinant Coagulation Factors Sales by Type
7.3 Europe Non-recombinant Coagulation Factors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-recombinant Coagulation Factors by Country
8.1.1 Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-recombinant Coagulation Factors Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-recombinant Coagulation Factors Sales by Type
8.3 Middle East & Africa Non-recombinant Coagulation Factors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors
10.3 Manufacturing Process Analysis of Non-recombinant Coagulation Factors
10.4 Industry Chain Structure of Non-recombinant Coagulation Factors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-recombinant Coagulation Factors Distributors
11.3 Non-recombinant Coagulation Factors Customer
12 WORLD FORECAST REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
12.1 Global Non-recombinant Coagulation Factors Market Size Forecast by Region
12.1.1 Global Non-recombinant Coagulation Factors Forecast by Region (2024-2029)
12.1.2 Global Non-recombinant Coagulation Factors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-recombinant Coagulation Factors Forecast by Type
12.7 Global Non-recombinant Coagulation Factors Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Instituto Grifols SA
13.2.1 Instituto Grifols SA Company Information
13.2.2 Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.2.3 Instituto Grifols SA Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Instituto Grifols SA Main Business Overview
13.2.5 Instituto Grifols SA Latest Developments
13.3 CSL Behring LLC
13.3.1 CSL Behring LLC Company Information
13.3.2 CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.3.3 CSL Behring LLC Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CSL Behring LLC Main Business Overview
13.3.5 CSL Behring LLC Latest Developments
13.4 KM Biologics KK
13.4.1 KM Biologics KK Company Information
13.4.2 KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.4.3 KM Biologics KK Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KM Biologics KK Main Business Overview
13.4.5 KM Biologics KK Latest Developments
13.5 Baxter Healthcare Corp.
13.5.1 Baxter Healthcare Corp. Company Information
13.5.2 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.5.3 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Baxter Healthcare Corp. Main Business Overview
13.5.5 Baxter Healthcare Corp. Latest Developments
13.6 Sanquin
13.6.1 Sanquin Company Information
13.6.2 Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.6.3 Sanquin Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanquin Main Business Overview
13.6.5 Sanquin Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.7.3 Johnson & Johnson Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Octapharma AG
13.8.1 Octapharma AG Company Information
13.8.2 Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.8.3 Octapharma AG Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Octapharma AG Main Business Overview
13.8.5 Octapharma AG Latest Developments
13.9 Bio Products Laboratory Ltd.
13.9.1 Bio Products Laboratory Ltd. Company Information
13.9.2 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.9.3 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bio Products Laboratory Ltd. Main Business Overview
13.9.5 Bio Products Laboratory Ltd. Latest Developments
13.10 Grifols Biologicals, Inc.
13.10.1 Grifols Biologicals, Inc. Company Information
13.10.2 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.10.3 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Grifols Biologicals, Inc. Main Business Overview
13.10.5 Grifols Biologicals, Inc. Latest Developments
13.11 Pfizer Inc.
13.11.1 Pfizer Inc. Company Information
13.11.2 Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.11.3 Pfizer Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Pfizer Inc. Main Business Overview
13.11.5 Pfizer Inc. Latest Developments
13.12 Intas Biopharmaceuticals Ltd.
13.12.1 Intas Biopharmaceuticals Ltd. Company Information
13.12.2 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.12.3 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Intas Biopharmaceuticals Ltd. Main Business Overview
13.12.5 Intas Biopharmaceuticals Ltd. Latest Developments
13.13 Shandong Taibang Biological Products
13.13.1 Shandong Taibang Biological Products Company Information
13.13.2 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.13.3 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Taibang Biological Products Main Business Overview
13.13.5 Shandong Taibang Biological Products Latest Developments
13.14 Sinopharm Group Shanghai Blood Products
13.14.1 Sinopharm Group Shanghai Blood Products Company Information
13.14.2 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.14.3 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sinopharm Group Shanghai Blood Products Main Business Overview
13.14.5 Sinopharm Group Shanghai Blood Products Latest Developments
13.15 SHANGHAI RAAS
13.15.1 SHANGHAI RAAS Company Information
13.15.2 SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.15.3 SHANGHAI RAAS Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 SHANGHAI RAAS Main Business Overview
13.15.5 SHANGHAI RAAS Latest Developments
13.16 China Resources Boya Bio-Pharmaceutical
13.16.1 China Resources Boya Bio-Pharmaceutical Company Information
13.16.2 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.16.3 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 China Resources Boya Bio-Pharmaceutical Main Business Overview
13.16.5 China Resources Boya Bio-Pharmaceutical Latest Developments
13.17 Chengdu Rongsheng Pharmaceuticals
13.17.1 Chengdu Rongsheng Pharmaceuticals Company Information
13.17.2 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.17.3 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Chengdu Rongsheng Pharmaceuticals Main Business Overview
13.17.5 Chengdu Rongsheng Pharmaceuticals Latest Developments
13.18 Yuanda Shuyang Pharmaceutical
13.18.1 Yuanda Shuyang Pharmaceutical Company Information
13.18.2 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.18.3 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Yuanda Shuyang Pharmaceutical Main Business Overview
13.18.5 Yuanda Shuyang Pharmaceutical Latest Developments
13.19 HUALAN BIO
13.19.1 HUALAN BIO Company Information
13.19.2 HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.19.3 HUALAN BIO Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 HUALAN BIO Main Business Overview
13.19.5 HUALAN BIO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-recombinant Coagulation Factors Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-recombinant Coagulation Factors by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-recombinant Coagulation Factors by Country/Region, 2018, 2022 & 2029
2.2 Non-recombinant Coagulation Factors Segment by Type
2.2.1 Coagulation Factor VIII
2.2.2 Human Fibrinogen
2.2.3 Others
2.3 Non-recombinant Coagulation Factors Sales by Type
2.3.1 Global Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
2.3.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-recombinant Coagulation Factors Sale Price by Type (2018-2023)
2.4 Non-recombinant Coagulation Factors Segment by Application
2.4.1 Hemophilia
2.4.2 Fibrinogen Deficiency
2.4.3 Other
2.5 Non-recombinant Coagulation Factors Sales by Application
2.5.1 Global Non-recombinant Coagulation Factors Sale Market Share by Application (2018-2023)
2.5.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-recombinant Coagulation Factors Sale Price by Application (2018-2023)
3 GLOBAL NON-RECOMBINANT COAGULATION FACTORS BY COMPANY
3.1 Global Non-recombinant Coagulation Factors Breakdown Data by Company
3.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Company (2018-2023)
3.1.2 Global Non-recombinant Coagulation Factors Sales Market Share by Company (2018-2023)
3.2 Global Non-recombinant Coagulation Factors Annual Revenue by Company (2018-2023)
3.2.1 Global Non-recombinant Coagulation Factors Revenue by Company (2018-2023)
3.2.2 Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2018-2023)
3.3 Global Non-recombinant Coagulation Factors Sale Price by Company
3.4 Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-recombinant Coagulation Factors Product Location Distribution
3.4.2 Players Non-recombinant Coagulation Factors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
4.1 World Historic Non-recombinant Coagulation Factors Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-recombinant Coagulation Factors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-recombinant Coagulation Factors Market Size by Country/Region (2018-2023)
4.2.1 Global Non-recombinant Coagulation Factors Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-recombinant Coagulation Factors Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-recombinant Coagulation Factors Sales Growth
4.4 APAC Non-recombinant Coagulation Factors Sales Growth
4.5 Europe Non-recombinant Coagulation Factors Sales Growth
4.6 Middle East & Africa Non-recombinant Coagulation Factors Sales Growth
5 AMERICAS
5.1 Americas Non-recombinant Coagulation Factors Sales by Country
5.1.1 Americas Non-recombinant Coagulation Factors Sales by Country (2018-2023)
5.1.2 Americas Non-recombinant Coagulation Factors Revenue by Country (2018-2023)
5.2 Americas Non-recombinant Coagulation Factors Sales by Type
5.3 Americas Non-recombinant Coagulation Factors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-recombinant Coagulation Factors Sales by Region
6.1.1 APAC Non-recombinant Coagulation Factors Sales by Region (2018-2023)
6.1.2 APAC Non-recombinant Coagulation Factors Revenue by Region (2018-2023)
6.2 APAC Non-recombinant Coagulation Factors Sales by Type
6.3 APAC Non-recombinant Coagulation Factors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-recombinant Coagulation Factors by Country
7.1.1 Europe Non-recombinant Coagulation Factors Sales by Country (2018-2023)
7.1.2 Europe Non-recombinant Coagulation Factors Revenue by Country (2018-2023)
7.2 Europe Non-recombinant Coagulation Factors Sales by Type
7.3 Europe Non-recombinant Coagulation Factors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-recombinant Coagulation Factors by Country
8.1.1 Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-recombinant Coagulation Factors Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-recombinant Coagulation Factors Sales by Type
8.3 Middle East & Africa Non-recombinant Coagulation Factors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors
10.3 Manufacturing Process Analysis of Non-recombinant Coagulation Factors
10.4 Industry Chain Structure of Non-recombinant Coagulation Factors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-recombinant Coagulation Factors Distributors
11.3 Non-recombinant Coagulation Factors Customer
12 WORLD FORECAST REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
12.1 Global Non-recombinant Coagulation Factors Market Size Forecast by Region
12.1.1 Global Non-recombinant Coagulation Factors Forecast by Region (2024-2029)
12.1.2 Global Non-recombinant Coagulation Factors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-recombinant Coagulation Factors Forecast by Type
12.7 Global Non-recombinant Coagulation Factors Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Instituto Grifols SA
13.2.1 Instituto Grifols SA Company Information
13.2.2 Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.2.3 Instituto Grifols SA Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Instituto Grifols SA Main Business Overview
13.2.5 Instituto Grifols SA Latest Developments
13.3 CSL Behring LLC
13.3.1 CSL Behring LLC Company Information
13.3.2 CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.3.3 CSL Behring LLC Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CSL Behring LLC Main Business Overview
13.3.5 CSL Behring LLC Latest Developments
13.4 KM Biologics KK
13.4.1 KM Biologics KK Company Information
13.4.2 KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.4.3 KM Biologics KK Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KM Biologics KK Main Business Overview
13.4.5 KM Biologics KK Latest Developments
13.5 Baxter Healthcare Corp.
13.5.1 Baxter Healthcare Corp. Company Information
13.5.2 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.5.3 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Baxter Healthcare Corp. Main Business Overview
13.5.5 Baxter Healthcare Corp. Latest Developments
13.6 Sanquin
13.6.1 Sanquin Company Information
13.6.2 Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.6.3 Sanquin Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanquin Main Business Overview
13.6.5 Sanquin Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.7.3 Johnson & Johnson Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Octapharma AG
13.8.1 Octapharma AG Company Information
13.8.2 Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.8.3 Octapharma AG Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Octapharma AG Main Business Overview
13.8.5 Octapharma AG Latest Developments
13.9 Bio Products Laboratory Ltd.
13.9.1 Bio Products Laboratory Ltd. Company Information
13.9.2 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.9.3 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bio Products Laboratory Ltd. Main Business Overview
13.9.5 Bio Products Laboratory Ltd. Latest Developments
13.10 Grifols Biologicals, Inc.
13.10.1 Grifols Biologicals, Inc. Company Information
13.10.2 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.10.3 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Grifols Biologicals, Inc. Main Business Overview
13.10.5 Grifols Biologicals, Inc. Latest Developments
13.11 Pfizer Inc.
13.11.1 Pfizer Inc. Company Information
13.11.2 Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.11.3 Pfizer Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Pfizer Inc. Main Business Overview
13.11.5 Pfizer Inc. Latest Developments
13.12 Intas Biopharmaceuticals Ltd.
13.12.1 Intas Biopharmaceuticals Ltd. Company Information
13.12.2 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.12.3 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Intas Biopharmaceuticals Ltd. Main Business Overview
13.12.5 Intas Biopharmaceuticals Ltd. Latest Developments
13.13 Shandong Taibang Biological Products
13.13.1 Shandong Taibang Biological Products Company Information
13.13.2 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.13.3 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong Taibang Biological Products Main Business Overview
13.13.5 Shandong Taibang Biological Products Latest Developments
13.14 Sinopharm Group Shanghai Blood Products
13.14.1 Sinopharm Group Shanghai Blood Products Company Information
13.14.2 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.14.3 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sinopharm Group Shanghai Blood Products Main Business Overview
13.14.5 Sinopharm Group Shanghai Blood Products Latest Developments
13.15 SHANGHAI RAAS
13.15.1 SHANGHAI RAAS Company Information
13.15.2 SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.15.3 SHANGHAI RAAS Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 SHANGHAI RAAS Main Business Overview
13.15.5 SHANGHAI RAAS Latest Developments
13.16 China Resources Boya Bio-Pharmaceutical
13.16.1 China Resources Boya Bio-Pharmaceutical Company Information
13.16.2 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.16.3 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 China Resources Boya Bio-Pharmaceutical Main Business Overview
13.16.5 China Resources Boya Bio-Pharmaceutical Latest Developments
13.17 Chengdu Rongsheng Pharmaceuticals
13.17.1 Chengdu Rongsheng Pharmaceuticals Company Information
13.17.2 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.17.3 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Chengdu Rongsheng Pharmaceuticals Main Business Overview
13.17.5 Chengdu Rongsheng Pharmaceuticals Latest Developments
13.18 Yuanda Shuyang Pharmaceutical
13.18.1 Yuanda Shuyang Pharmaceutical Company Information
13.18.2 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.18.3 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Yuanda Shuyang Pharmaceutical Main Business Overview
13.18.5 Yuanda Shuyang Pharmaceutical Latest Developments
13.19 HUALAN BIO
13.19.1 HUALAN BIO Company Information
13.19.2 HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.19.3 HUALAN BIO Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 HUALAN BIO Main Business Overview
13.19.5 HUALAN BIO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-recombinant Coagulation Factors Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-recombinant Coagulation Factors Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Coagulation Factor VIII
Table 4. Major Players of Human Fibrinogen
Table 5. Major Players of Others
Table 6. Global Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 7. Global Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Table 8. Global Non-recombinant Coagulation Factors Revenue by Type (2018-2023) & ($ million)
Table 9. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2018-2023)
Table 10. Global Non-recombinant Coagulation Factors Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 12. Global Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Table 13. Global Non-recombinant Coagulation Factors Revenue by Application (2018-2023)
Table 14. Global Non-recombinant Coagulation Factors Revenue Market Share by Application (2018-2023)
Table 15. Global Non-recombinant Coagulation Factors Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Non-recombinant Coagulation Factors Sales by Company (2018-2023) & (K Units)
Table 17. Global Non-recombinant Coagulation Factors Sales Market Share by Company (2018-2023)
Table 18. Global Non-recombinant Coagulation Factors Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2018-2023)
Table 20. Global Non-recombinant Coagulation Factors Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution and Sales Area
Table 22. Players Non-recombinant Coagulation Factors Products Offered
Table 23. Non-recombinant Coagulation Factors Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Non-recombinant Coagulation Factors Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Non-recombinant Coagulation Factors Sales Market Share Geographic Region (2018-2023)
Table 28. Global Non-recombinant Coagulation Factors Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Non-recombinant Coagulation Factors Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2018-2023)
Table 32. Global Non-recombinant Coagulation Factors Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Non-recombinant Coagulation Factors Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Non-recombinant Coagulation Factors Sales by Country (2018-2023) & (K Units)
Table 35. Americas Non-recombinant Coagulation Factors Sales Market Share by Country (2018-2023)
Table 36. Americas Non-recombinant Coagulation Factors Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Non-recombinant Coagulation Factors Revenue Market Share by Country (2018-2023)
Table 38. Americas Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 39. Americas Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 40. APAC Non-recombinant Coagulation Factors Sales by Region (2018-2023) & (K Units)
Table 41. APAC Non-recombinant Coagulation Factors Sales Market Share by Region (2018-2023)
Table 42. APAC Non-recombinant Coagulation Factors Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Non-recombinant Coagulation Factors Revenue Market Share by Region (2018-2023)
Table 44. APAC Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 45. APAC Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 46. Europe Non-recombinant Coagulation Factors Sales by Country (2018-2023) & (K Units)
Table 47. Europe Non-recombinant Coagulation Factors Sales Market Share by Country (2018-2023)
Table 48. Europe Non-recombinant Coagulation Factors Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Non-recombinant Coagulation Factors Revenue Market Share by Country (2018-2023)
Table 50. Europe Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 51. Europe Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Non-recombinant Coagulation Factors Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Non-recombinant Coagulation Factors Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Non-recombinant Coagulation Factors
Table 59. Key Market Challenges & Risks of Non-recombinant Coagulation Factors
Table 60. Key Industry Trends of Non-recombinant Coagulation Factors
Table 61. Non-recombinant Coagulation Factors Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Non-recombinant Coagulation Factors Distributors List
Table 64. Non-recombinant Coagulation Factors Customer List
Table 65. Global Non-recombinant Coagulation Factors Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Non-recombinant Coagulation Factors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Non-recombinant Coagulation Factors Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Non-recombinant Coagulation Factors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Non-recombinant Coagulation Factors Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Non-recombinant Coagulation Factors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Non-recombinant Coagulation Factors Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Non-recombinant Coagulation Factors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Non-recombinant Coagulation Factors Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Non-recombinant Coagulation Factors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Non-recombinant Coagulation Factors Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Non-recombinant Coagulation Factors Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Non-recombinant Coagulation Factors Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Non-recombinant Coagulation Factors Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Takeda Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 80. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 81. Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Takeda Pharmaceutical Main Business
Table 83. Takeda Pharmaceutical Latest Developments
Table 84. Instituto Grifols SA Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 85. Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 86. Instituto Grifols SA Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Instituto Grifols SA Main Business
Table 88. Instituto Grifols SA Latest Developments
Table 89. CSL Behring LLC Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 90. CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 91. CSL Behring LLC Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. CSL Behring LLC Main Business
Table 93. CSL Behring LLC Latest Developments
Table 94. KM Biologics KK Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 95. KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 96. KM Biologics KK Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. KM Biologics KK Main Business
Table 98. KM Biologics KK Latest Developments
Table 99. Baxter Healthcare Corp. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 100. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 101. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Baxter Healthcare Corp. Main Business
Table 103. Baxter Healthcare Corp. Latest Developments
Table 104. Sanquin Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 106. Sanquin Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Sanquin Main Business
Table 108. Sanquin Latest Developments
Table 109. Johnson & Johnson Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 110. Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 111. Johnson & Johnson Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Johnson & Johnson Main Business
Table 113. Johnson & Johnson Latest Developments
Table 114. Octapharma AG Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 115. Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 116. Octapharma AG Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Octapharma AG Main Business
Table 118. Octapharma AG Latest Developments
Table 119. Bio Products Laboratory Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 120. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 121. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Bio Products Laboratory Ltd. Main Business
Table 123. Bio Products Laboratory Ltd. Latest Developments
Table 124. Grifols Biologicals, Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 125. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 126. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Grifols Biologicals, Inc. Main Business
Table 128. Grifols Biologicals, Inc. Latest Developments
Table 129. Pfizer Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 130. Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 131. Pfizer Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Pfizer Inc. Main Business
Table 133. Pfizer Inc. Latest Developments
Table 134. Intas Biopharmaceuticals Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 135. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 136. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Intas Biopharmaceuticals Ltd. Main Business
Table 138. Intas Biopharmaceuticals Ltd. Latest Developments
Table 139. Shandong Taibang Biological Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 140. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 141. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Shandong Taibang Biological Products Main Business
Table 143. Shandong Taibang Biological Products Latest Developments
Table 144. Sinopharm Group Shanghai Blood Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 145. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 146. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Sinopharm Group Shanghai Blood Products Main Business
Table 148. Sinopharm Group Shanghai Blood Products Latest Developments
Table 149. SHANGHAI RAAS Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 150. SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 151. SHANGHAI RAAS Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. SHANGHAI RAAS Main Business
Table 153. SHANGHAI RAAS Latest Developments
Table 154. China Resources Boya Bio-Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 155. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 156. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. China Resources Boya Bio-Pharmaceutical Main Business
Table 158. China Resources Boya Bio-Pharmaceutical Latest Developments
Table 159. Chengdu Rongsheng Pharmaceuticals Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 160. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 161. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Chengdu Rongsheng Pharmaceuticals Main Business
Table 163. Chengdu Rongsheng Pharmaceuticals Latest Developments
Table 164. Yuanda Shuyang Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 165. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 166. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Yuanda Shuyang Pharmaceutical Main Business
Table 168. Yuanda Shuyang Pharmaceutical Latest Developments
Table 169. HUALAN BIO Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 170. HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 171. HUALAN BIO Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. HUALAN BIO Main Business
Table 173. HUALAN BIO Latest Developments
Table 1. Non-recombinant Coagulation Factors Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-recombinant Coagulation Factors Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Coagulation Factor VIII
Table 4. Major Players of Human Fibrinogen
Table 5. Major Players of Others
Table 6. Global Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 7. Global Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Table 8. Global Non-recombinant Coagulation Factors Revenue by Type (2018-2023) & ($ million)
Table 9. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2018-2023)
Table 10. Global Non-recombinant Coagulation Factors Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 12. Global Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Table 13. Global Non-recombinant Coagulation Factors Revenue by Application (2018-2023)
Table 14. Global Non-recombinant Coagulation Factors Revenue Market Share by Application (2018-2023)
Table 15. Global Non-recombinant Coagulation Factors Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Non-recombinant Coagulation Factors Sales by Company (2018-2023) & (K Units)
Table 17. Global Non-recombinant Coagulation Factors Sales Market Share by Company (2018-2023)
Table 18. Global Non-recombinant Coagulation Factors Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2018-2023)
Table 20. Global Non-recombinant Coagulation Factors Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution and Sales Area
Table 22. Players Non-recombinant Coagulation Factors Products Offered
Table 23. Non-recombinant Coagulation Factors Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Non-recombinant Coagulation Factors Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Non-recombinant Coagulation Factors Sales Market Share Geographic Region (2018-2023)
Table 28. Global Non-recombinant Coagulation Factors Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Non-recombinant Coagulation Factors Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2018-2023)
Table 32. Global Non-recombinant Coagulation Factors Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Non-recombinant Coagulation Factors Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Non-recombinant Coagulation Factors Sales by Country (2018-2023) & (K Units)
Table 35. Americas Non-recombinant Coagulation Factors Sales Market Share by Country (2018-2023)
Table 36. Americas Non-recombinant Coagulation Factors Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Non-recombinant Coagulation Factors Revenue Market Share by Country (2018-2023)
Table 38. Americas Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 39. Americas Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 40. APAC Non-recombinant Coagulation Factors Sales by Region (2018-2023) & (K Units)
Table 41. APAC Non-recombinant Coagulation Factors Sales Market Share by Region (2018-2023)
Table 42. APAC Non-recombinant Coagulation Factors Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Non-recombinant Coagulation Factors Revenue Market Share by Region (2018-2023)
Table 44. APAC Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 45. APAC Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 46. Europe Non-recombinant Coagulation Factors Sales by Country (2018-2023) & (K Units)
Table 47. Europe Non-recombinant Coagulation Factors Sales Market Share by Country (2018-2023)
Table 48. Europe Non-recombinant Coagulation Factors Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Non-recombinant Coagulation Factors Revenue Market Share by Country (2018-2023)
Table 50. Europe Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 51. Europe Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Non-recombinant Coagulation Factors Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Non-recombinant Coagulation Factors Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Non-recombinant Coagulation Factors Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Non-recombinant Coagulation Factors Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Non-recombinant Coagulation Factors
Table 59. Key Market Challenges & Risks of Non-recombinant Coagulation Factors
Table 60. Key Industry Trends of Non-recombinant Coagulation Factors
Table 61. Non-recombinant Coagulation Factors Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Non-recombinant Coagulation Factors Distributors List
Table 64. Non-recombinant Coagulation Factors Customer List
Table 65. Global Non-recombinant Coagulation Factors Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Non-recombinant Coagulation Factors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Non-recombinant Coagulation Factors Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Non-recombinant Coagulation Factors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Non-recombinant Coagulation Factors Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Non-recombinant Coagulation Factors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Non-recombinant Coagulation Factors Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Non-recombinant Coagulation Factors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Non-recombinant Coagulation Factors Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Non-recombinant Coagulation Factors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Non-recombinant Coagulation Factors Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Non-recombinant Coagulation Factors Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Non-recombinant Coagulation Factors Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Non-recombinant Coagulation Factors Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Takeda Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 80. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 81. Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Takeda Pharmaceutical Main Business
Table 83. Takeda Pharmaceutical Latest Developments
Table 84. Instituto Grifols SA Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 85. Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 86. Instituto Grifols SA Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Instituto Grifols SA Main Business
Table 88. Instituto Grifols SA Latest Developments
Table 89. CSL Behring LLC Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 90. CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 91. CSL Behring LLC Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. CSL Behring LLC Main Business
Table 93. CSL Behring LLC Latest Developments
Table 94. KM Biologics KK Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 95. KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 96. KM Biologics KK Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. KM Biologics KK Main Business
Table 98. KM Biologics KK Latest Developments
Table 99. Baxter Healthcare Corp. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 100. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 101. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Baxter Healthcare Corp. Main Business
Table 103. Baxter Healthcare Corp. Latest Developments
Table 104. Sanquin Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 106. Sanquin Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Sanquin Main Business
Table 108. Sanquin Latest Developments
Table 109. Johnson & Johnson Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 110. Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 111. Johnson & Johnson Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Johnson & Johnson Main Business
Table 113. Johnson & Johnson Latest Developments
Table 114. Octapharma AG Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 115. Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 116. Octapharma AG Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Octapharma AG Main Business
Table 118. Octapharma AG Latest Developments
Table 119. Bio Products Laboratory Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 120. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 121. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Bio Products Laboratory Ltd. Main Business
Table 123. Bio Products Laboratory Ltd. Latest Developments
Table 124. Grifols Biologicals, Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 125. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 126. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Grifols Biologicals, Inc. Main Business
Table 128. Grifols Biologicals, Inc. Latest Developments
Table 129. Pfizer Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 130. Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 131. Pfizer Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Pfizer Inc. Main Business
Table 133. Pfizer Inc. Latest Developments
Table 134. Intas Biopharmaceuticals Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 135. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 136. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Intas Biopharmaceuticals Ltd. Main Business
Table 138. Intas Biopharmaceuticals Ltd. Latest Developments
Table 139. Shandong Taibang Biological Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 140. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 141. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Shandong Taibang Biological Products Main Business
Table 143. Shandong Taibang Biological Products Latest Developments
Table 144. Sinopharm Group Shanghai Blood Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 145. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 146. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Sinopharm Group Shanghai Blood Products Main Business
Table 148. Sinopharm Group Shanghai Blood Products Latest Developments
Table 149. SHANGHAI RAAS Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 150. SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 151. SHANGHAI RAAS Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. SHANGHAI RAAS Main Business
Table 153. SHANGHAI RAAS Latest Developments
Table 154. China Resources Boya Bio-Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 155. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 156. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. China Resources Boya Bio-Pharmaceutical Main Business
Table 158. China Resources Boya Bio-Pharmaceutical Latest Developments
Table 159. Chengdu Rongsheng Pharmaceuticals Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 160. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 161. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Chengdu Rongsheng Pharmaceuticals Main Business
Table 163. Chengdu Rongsheng Pharmaceuticals Latest Developments
Table 164. Yuanda Shuyang Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 165. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 166. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Yuanda Shuyang Pharmaceutical Main Business
Table 168. Yuanda Shuyang Pharmaceutical Latest Developments
Table 169. HUALAN BIO Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 170. HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 171. HUALAN BIO Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. HUALAN BIO Main Business
Table 173. HUALAN BIO Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-recombinant Coagulation Factors
Figure 2. Non-recombinant Coagulation Factors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-recombinant Coagulation Factors Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-recombinant Coagulation Factors Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-recombinant Coagulation Factors Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Coagulation Factor VIII
Figure 10. Product Picture of Human Fibrinogen
Figure 11. Product Picture of Others
Figure 12. Global Non-recombinant Coagulation Factors Sales Market Share by Type in 2022
Figure 13. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2018-2023)
Figure 14. Non-recombinant Coagulation Factors Consumed in Hemophilia
Figure 15. Global Non-recombinant Coagulation Factors Market: Hemophilia (2018-2023) & (K Units)
Figure 16. Non-recombinant Coagulation Factors Consumed in Fibrinogen Deficiency
Figure 17. Global Non-recombinant Coagulation Factors Market: Fibrinogen Deficiency (2018-2023) & (K Units)
Figure 18. Non-recombinant Coagulation Factors Consumed in Other
Figure 19. Global Non-recombinant Coagulation Factors Market: Other (2018-2023) & (K Units)
Figure 20. Global Non-recombinant Coagulation Factors Sales Market Share by Application (2022)
Figure 21. Global Non-recombinant Coagulation Factors Revenue Market Share by Application in 2022
Figure 22. Non-recombinant Coagulation Factors Sales Market by Company in 2022 (K Units)
Figure 23. Global Non-recombinant Coagulation Factors Sales Market Share by Company in 2022
Figure 24. Non-recombinant Coagulation Factors Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Non-recombinant Coagulation Factors Revenue Market Share by Company in 2022
Figure 26. Global Non-recombinant Coagulation Factors Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 29. Americas Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 30. APAC Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 31. APAC Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 32. Europe Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 33. Europe Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 36. Americas Non-recombinant Coagulation Factors Sales Market Share by Country in 2022
Figure 37. Americas Non-recombinant Coagulation Factors Revenue Market Share by Country in 2022
Figure 38. Americas Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 39. Americas Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 40. United States Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Non-recombinant Coagulation Factors Sales Market Share by Region in 2022
Figure 45. APAC Non-recombinant Coagulation Factors Revenue Market Share by Regions in 2022
Figure 46. APAC Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 47. APAC Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 48. China Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Non-recombinant Coagulation Factors Sales Market Share by Country in 2022
Figure 56. Europe Non-recombinant Coagulation Factors Revenue Market Share by Country in 2022
Figure 57. Europe Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 58. Europe Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 59. Germany Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Non-recombinant Coagulation Factors Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 68. Egypt Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors in 2022
Figure 74. Manufacturing Process Analysis of Non-recombinant Coagulation Factors
Figure 75. Industry Chain Structure of Non-recombinant Coagulation Factors
Figure 76. Channels of Distribution
Figure 77. Global Non-recombinant Coagulation Factors Sales Market Forecast by Region (2024-2029)
Figure 78. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Non-recombinant Coagulation Factors
Figure 2. Non-recombinant Coagulation Factors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-recombinant Coagulation Factors Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-recombinant Coagulation Factors Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-recombinant Coagulation Factors Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Coagulation Factor VIII
Figure 10. Product Picture of Human Fibrinogen
Figure 11. Product Picture of Others
Figure 12. Global Non-recombinant Coagulation Factors Sales Market Share by Type in 2022
Figure 13. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2018-2023)
Figure 14. Non-recombinant Coagulation Factors Consumed in Hemophilia
Figure 15. Global Non-recombinant Coagulation Factors Market: Hemophilia (2018-2023) & (K Units)
Figure 16. Non-recombinant Coagulation Factors Consumed in Fibrinogen Deficiency
Figure 17. Global Non-recombinant Coagulation Factors Market: Fibrinogen Deficiency (2018-2023) & (K Units)
Figure 18. Non-recombinant Coagulation Factors Consumed in Other
Figure 19. Global Non-recombinant Coagulation Factors Market: Other (2018-2023) & (K Units)
Figure 20. Global Non-recombinant Coagulation Factors Sales Market Share by Application (2022)
Figure 21. Global Non-recombinant Coagulation Factors Revenue Market Share by Application in 2022
Figure 22. Non-recombinant Coagulation Factors Sales Market by Company in 2022 (K Units)
Figure 23. Global Non-recombinant Coagulation Factors Sales Market Share by Company in 2022
Figure 24. Non-recombinant Coagulation Factors Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Non-recombinant Coagulation Factors Revenue Market Share by Company in 2022
Figure 26. Global Non-recombinant Coagulation Factors Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 29. Americas Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 30. APAC Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 31. APAC Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 32. Europe Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 33. Europe Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Non-recombinant Coagulation Factors Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Non-recombinant Coagulation Factors Revenue 2018-2023 ($ Millions)
Figure 36. Americas Non-recombinant Coagulation Factors Sales Market Share by Country in 2022
Figure 37. Americas Non-recombinant Coagulation Factors Revenue Market Share by Country in 2022
Figure 38. Americas Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 39. Americas Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 40. United States Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Non-recombinant Coagulation Factors Sales Market Share by Region in 2022
Figure 45. APAC Non-recombinant Coagulation Factors Revenue Market Share by Regions in 2022
Figure 46. APAC Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 47. APAC Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 48. China Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Non-recombinant Coagulation Factors Sales Market Share by Country in 2022
Figure 56. Europe Non-recombinant Coagulation Factors Revenue Market Share by Country in 2022
Figure 57. Europe Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 58. Europe Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 59. Germany Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Non-recombinant Coagulation Factors Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Application (2018-2023)
Figure 68. Egypt Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Non-recombinant Coagulation Factors Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors in 2022
Figure 74. Manufacturing Process Analysis of Non-recombinant Coagulation Factors
Figure 75. Industry Chain Structure of Non-recombinant Coagulation Factors
Figure 76. Channels of Distribution
Figure 77. Global Non-recombinant Coagulation Factors Sales Market Forecast by Region (2024-2029)
Figure 78. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Application (2024-2029)
